Statistiche di base
| CIK | 1845257 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to LifeStance Health Group, Inc.
SEC Filings (Chronological Order)
Questa pagina fornisce un elenco completo e cronologico dei depositi SEC, esclusi i documenti di proprietà che forniamo altrove.
| August 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 19, 2025 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Comm |
|
| August 7, 2025 |
LifeStance Reports Second Quarter 2025 Results Exhibit 99.1 Investor Relations Contact Monica Prokocki VP of Finance & Investor Relations 602-767-2100 [email protected] LifeStance Reports Second Quarter 2025 Results SCOTTSDALE, Ariz. – August 7, 2025 – LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the second quarter ende |
|
| August 7, 2025 |
Exhibit 10.1 SEPARATION AND RELEASE OF CLAIMS AGREEMENT This Separation and Release of Claims Agreement (the “Agreement”) is entered into by and between LifeStance Health Group, Inc. (“LifeStance”), and Pablo Pantaleoni (“Employee”). RECITALS A. Prior to July 1, 2025 (the “Termination Date”), Employee was employed by LifeStance; B. Employee and LifeStance have agreed to separate effective on the T |
|
| August 7, 2025 |
Exhibit 10.2 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this “Agreement”), by and between LifeStance Health Group, Inc. (the “Company”), a Delaware corporation with its principal place of business in Scottsdale, Arizona, and Vaughn Paunovich (the “Executive”), is entered into as of May 12, 2025 and is effective as of the date the Executive actually commences employment with the Company (the “ |
|
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 07, 2025 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Comm |
|
| August 7, 2025 |
Reimagining Mental Health Q2 2025 Earnings Presentation • August 7, 2025 Exhibit 99. |
|
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40478 LifeStance Health Group, Inc. |
|
| June 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2025 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| May 14, 2025 |
LIFESTANCE NAMES VAUGHN PAUNOVICH AS CHIEF TECHNOLOGY OFFICER EX-99.1 Exhibit 99.1 LIFESTANCE NAMES VAUGHN PAUNOVICH AS CHIEF TECHNOLOGY OFFICER SCOTTSDALE, Ariz. - May 14, 2025 - LifeStance Health, one of the nation’s largest providers of virtual and in-person outpatient mental health care, today announced that Vaughn Paunovich will join the company as Chief Technology Officer, effective Monday, June 9, 2025. Paunovich will lead LifeStance’s end-to-end tech |
|
| May 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2025 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| May 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40478 LifeStance Health Group, Inc. |
|
| May 7, 2025 |
Reimagining Mental Health Q1 2025 Earnings Presentation • May 7, 2025 Exhibit 99.2 Forward-Looking Statements DISCLAIMERS Cautionary Note Regarding Forward-Looking Statements This presentation and related oral statements, including during any question and answer portion of the presentation, contain forward-looking statements about LifeStance Health Group, Inc. and its subsidiaries (“LifeStance”) a |
|
| May 7, 2025 |
LifeStance Reports First Quarter 2025 Results Exhibit 99.1 Investor Relations Contact Monica Prokocki VP of Finance & Investor Relations 602-767-2100 [email protected] LifeStance Reports First Quarter 2025 Results SCOTTSDALE, Ariz. – May 7, 2025 – LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the first quarter ended Mar |
|
| May 7, 2025 |
Exhibit 10.3 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this “Agreement”), by and between LifeStance Health Group, Inc. (the “Company”), a Delaware corporation with its principal place of business in Scottsdale, Arizona, and Ryan McGroarty (the “Executive”), is entered into as of February 25, 2025 and is effective as of the date the Executive actually commences employment with the Company (th |
|
| May 7, 2025 |
Exhibit 10.2 FIRST AMENDMENT TO EMPLOYMENT AGREEMENT THIS FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”), by and between LifeStance Health Group, Inc. (the “Company”), a Delaware corporation with its principal place of business in Scottsdale, Arizona, and David Bourdon (the “Executive”), is entered into effective March 3, 2025 (the “Amendment Effective Date”) and amends the Employment |
|
| May 7, 2025 |
Exhibit 10.1 FIRST AMENDMENT TO EMPLOYMENT AGREEMENT THIS FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”), by and between LifeStance Health Group, Inc. (the “Company”), a Delaware corporation with its principal place of business in Scottsdale, Arizona, and Kenneth Burdick (the “Executive”), is entered into effective March 3, 2025 (the “Amendment Effective Date”) and amends the Employmen |
|
| May 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 07, 2025 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| April 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin |
|
| April 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin |
|
| February 27, 2025 |
Exhibit 99.1 LifeStance Appoints Dave Bourdon as CEO; Ken Burdick Named Executive Chairman Ryan McGroarty to Become Chief Financial Officer SCOTTSDALE, Ariz., Feb. 27, 2025 — LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental health care, today announced that its Board of Directors has appointed Dave Bourdon as t |
|
| February 27, 2025 |
Exhibit 10.19 Execution Version CREDIT AGREEMENT Dated as of December 19, 2024 among LIFESTANCE HEALTH HOLDINGS, INC., as the Borrower, LYNNWOOD INTERMEDIATE HOLDINGS, INC., as Holdings, CAPITAL ONE, NATIONAL ASSOCIATION as Administrative Agent, Collateral Agent, Issuing Bank and Swing Line Lender, and THE OTHER LENDERS PARTY HERETO CAPITAL ONE, NATIONAL ASSOCIATION, CITIZENS BANK, NATIONAL ASSOCI |
|
| February 27, 2025 |
LifeStance Health Group, Inc. Insider Trading Policy Exhibit 19.1 INSIDER TRADING POLICY OF LIFESTANCE HEALTH GROUP, INC. SECTION 1 PURPOSE This Insider Trading Policy (this “Policy”) provides guidelines with respect to transactions in the securities of LifeStance Health Group, Inc. (the “Corporation”) and the handling of confidential information about the Corporation and the companies with which the Corporation does business. The Corporation’s Boar |
|
| February 27, 2025 |
Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) LifeStance Health Group, Inc. |
|
| February 27, 2025 |
Reimagining Mental Health Q4 2024 Earnings Presentation • February 27, 2025 Exhibit 99. |
|
| February 27, 2025 |
List of subsidiaries of LifeStance Health Group, Inc. Exhibit 21.1 Subsidiaries of the Registrant Entity Jurisdiction Subsidiaries of LifeStance Health Group, Inc. LifeStance TopCo, L.P. Delaware Subsidiaries of LifeStance TopCo, L.P. LifeStance Ultimate Holdings, Inc. Delaware Subsidiaries of LifeStance Ultimate Holdings, Inc. Lynnwood Intermediate Holdings, Inc. Delaware Subsidiaries of Lynnwood Intermediate Holdings, Inc. LifeStance Health Holding |
|
| February 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-40478 LifeStance Heal |
|
| February 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 25, 2025 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Co |
|
| February 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2025 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Co |
|
| February 27, 2025 |
As filed with the Securities and Exchange Commission on February 27, 2025 As filed with the Securities and Exchange Commission on February 27, 2025 Registration No. |
|
| February 27, 2025 |
LifeStance Reports Fourth Quarter and Full Year 2024 Results Exhibit 99.1 Investor Relations Contact Monica Prokocki VP of Finance & Investor Relations 602-767-2100 [email protected] LifeStance Reports Fourth Quarter and Full Year 2024 Results SCOTTSDALE, Ariz. – February 27, 2025 – LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the fo |
|
| December 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 19, 2024 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Co |
|
| November 14, 2024 |
LFST / LifeStance Health Group, Inc. / Silversmith Partners I GP, LLC - SC 13G/A Passive Investment SC 13G/A 1 d900850dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* LifeStance Health Group, Inc. (Name of Issuer) Common stock, par value $0.01 per share (Title of Class of Securities) 53228F101 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statemen |
|
| November 14, 2024 |
LFST / LifeStance Health Group, Inc. / TPG GP A, LLC - AMENDMENT TO FORM SC 13G Passive Investment SC 13G/A 1 lfstsc13ga-093024.htm AMENDMENT TO FORM SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. 1)* Under the Securities Exchange Act of 1934 LifeStance Health Group, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Titles of Class of Securities) 53228F101 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Fil |
|
| November 8, 2024 |
LFST / LifeStance Health Group, Inc. / SUMMIT PARTNERS L P - SC 13G/A Passive Investment SC 13G/A 1 d899837dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* LifeStance Health Group, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 53228F101 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statemen |
|
| November 7, 2024 |
Exhibit 10.1 THIRD AMENDMENT TO CREDIT AGREEMENT THIS THIRD AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) is entered into as of August 7, 2024, by and among LifeStance Health Holdings, Inc., a Delaware corporation (the “Borrower”) and the Lenders party hereto, constituting all Term Lenders with outstanding Closing Date Term Loans, outstanding Delayed Draw Term Loans and Delayed Draw Term Loan C |
|
| November 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 07, 2024 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Co |
|
| November 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40478 LifeStance Health Group, Inc. |
|
| November 7, 2024 |
Reimagining Mental Health Q3 2024 Earnings Presentation • November 7, 2024 Exhibit 99. |
|
| November 7, 2024 |
LifeStance Reports Third Quarter 2024 Results Exhibit 99.1 Investor Relations Contact Monica Prokocki VP of Finance & Investor Relations 602-767-2100 [email protected] LifeStance Reports Third Quarter 2024 Results SCOTTSDALE, Ariz. – November 7, 2024 – LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the third quarter ende |
|
| August 8, 2024 |
Exhibit 10.2 SEPARATION AND RELEASE OF CLAIMS AGREEMENT This Separation and Release of Claims Agreement (this “Agreement”) is entered into by LifeStance Health Group, Inc. (“LifeStance”), LifeStance Health, Inc. (the “Company”, and collectively with LifeStance and its affiliates, the “Company Group”) and Danish Qureshi (“Employee”) on June 30th, 2024. For purposes of this Agreement, “affiliates” m |
|
| August 8, 2024 |
Reimagining Mental Health Q2 2024 Earnings Presentation • August 8, 2024 Exhibit 99. |
|
| August 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 08, 2024 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Comm |
|
| August 8, 2024 |
Exhibit 10.1 SECOND AMENDMENT TO CREDIT AGREEMENT THIS SECOND AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) is entered into as of May 10, 2024, by and among LifeStance Health Holdings, Inc., a Delaware corporation (the “Borrower”) and the Lenders party hereto. WHEREAS, reference is made to that certain Credit Agreement dated as of May 4, 2022 (as amended by that certain First Amendment to Credi |
|
| August 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40478 LifeStance Health Group, Inc. |
|
| August 8, 2024 |
LifeStance Reports Second Quarter 2024 Results Exhibit 99.1 Investor Relations Contact Monica Prokocki VP of Finance & Investor Relations 602-767-2100 [email protected] LifeStance Reports Second Quarter 2024 Results SCOTTSDALE, Ariz. – August 8, 2024 – LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the second quarter ende |
|
| July 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2024 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Commis |
|
| June 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2024 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| May 24, 2024 |
Exhibit 1.1 Execution Version 20,000,000 SHARES LIFESTANCE HEALTH GROUP, INC. COMMON STOCK, PAR VALUE $0.01 PER SHARE UNDERWRITING AGREEMENT May 21, 2024 Morgan Stanley & Co. LLC Goldman Sachs & Co. LLC As representatives of the several Underwriters listed in Schedule I hereto c/o Morgan Stanley & Co. LLC 1585 Broadway New York, NY 10036 c/o Goldman Sachs & Co. LLC 200 West Street New York, NY 102 |
|
| May 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 21, 2024 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| May 22, 2024 |
20,000,000 Shares LifeStance Health Group, Inc. Common Stock Table of Contents Filed Pursuant to Rule 424(b)(7) Registration No. 333-279585 PROSPECTUS SUPPLEMENT (To Prospectus dated May 21, 2024) 20,000,000 Shares LifeStance Health Group, Inc. Common Stock The selling stockholders identified in this prospectus supplement are offering 20,000,000 shares of common stock, par value $0.01 per share (the “common stock”), of LifeStance Health Group, Inc. (the “Co |
|
| May 22, 2024 |
EX-FILING FEES Exhibit 107 Calculation of Filing Fee Tables 424(b)(7) (Form Type) LIFESTANCE HEALTH GROUP, INC. |
|
| May 21, 2024 |
Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) LifeStance Health Group, Inc. |
|
| May 21, 2024 |
Subject to Completion, Dated May 21, 2024 Table of Contents Filed Pursuant to Rule 424(b)(7) Registration No. 333-279585 The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted. Subject to Completion, Date |
|
| May 21, 2024 |
As filed with the Securities and Exchange Commission on May 21, 2024 Table of Contents As filed with the Securities and Exchange Commission on May 21, 2024 Registration No. |
|
| May 9, 2024 |
LifeStance Reports First Quarter 2024 Results Exhibit 99.1 Investor Relations Contact Monica Prokocki VP of Finance & Investor Relations 602-767-2100 [email protected] LifeStance Reports First Quarter 2024 Results SCOTTSDALE, Ariz. – May 9, 2024 – LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the first quarter ended Mar |
|
| May 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 06, 2024 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| May 9, 2024 |
Reimagining Mental Health Q1 2024 Earnings Presentation • May 9, 2024 Exhibit 99.2 Forward-Looking Statements DISCLAIMERS Cautionary Note Regarding Forward-Looking Statements This presentation and related oral statements, including during any question and answer portion of the presentation, contain forward-looking statements about LifeStance Health Group, Inc. and its subsidiaries (“LifeStance”) a |
|
| May 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40478 LifeStance Health Group, Inc. |
|
| April 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin |
|
| April 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin |
|
| March 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2024 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Commi |
|
| February 28, 2024 |
Exhibit 10.19 Execution Version FIRST AMENDMENT TO CREDIT AGREEMENT THIS FIRST AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) is entered into as of November 7, 2023, by and among LifeStance Health Holdings, Inc., a Delaware corporation (the “Borrower”) and the Required Facility Lenders. WHEREAS, reference is made to that certain Credit Agreement dated as of May 4, 2022 (as amended, restated, sup |
|
| February 28, 2024 |
LifeStance Health Group, Inc. Policy for Recoupment of Incentive Compensation Exhibit 97.1 LifeStance Health Group, Inc. POLICY FOR RECOUPMENT OF INCENTIVE COMPENSATION 1. Introduction In accordance with Section 10D of the Securities Exchange Act of 1934, as amended, and the regulations thereunder, the Board of Directors (the “Board”) of LifeStance Health Group, Inc. (the “Company”) has adopted a policy (the “Policy”) providing for the Company’s recoupment of certain incent |
|
| February 28, 2024 |
As filed with the Securities and Exchange Commission on February 28, 2024 As filed with the Securities and Exchange Commission on February 28, 2024 Registration No. |
|
| February 28, 2024 |
List of subsidiaries of LifeStance Health Group, Inc. Exhibit 21.1 Subsidiaries of the Registrant Entity Jurisdiction Subsidiaries of LifeStance Health Group, Inc. LifeStance TopCo, L.P. Delaware Subsidiaries of LifeStance TopCo, L.P. LifeStance Ultimate Holdings, Inc. Delaware Subsidiaries of LifeStance Ultimate Holdings, Inc. Lynnwood Intermediate Holdings, Inc. Delaware Subsidiaries of Lynnwood Intermediate Holdings, Inc. LifeStance Health Holding |
|
| February 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2024 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Co |
|
| February 28, 2024 |
Reimagining Mental Health Q4 2023 Earnings Presentation • February 28, 2024 Exhibit 99. |
|
| February 28, 2024 |
LifeStance Reports Fourth Quarter and Full Year 2023 Results Exhibit 99.1 Investor Relations Contact Monica Prokocki VP of Finance & Investor Relations 602-767-2100 [email protected] LifeStance Reports Fourth Quarter and Full Year 2023 Results SCOTTSDALE, Ariz. – February 28, 2024 – LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the fo |
|
| February 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-40478 LifeStance Heal |
|
| February 28, 2024 |
Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) LifeStance Health Group, Inc. |
|
| February 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 2, 2024 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Com |
|
| January 24, 2024 |
LFST / LifeStance Health Group, Inc. / Lester Michael K. - SC 13G/A Passive Investment SC 13G/A 1 d122272dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* LifeStance Health Group, Inc. (Name of Issuer) Common stock, par value $0.01 per share (Title of Class of Securities) 53228F101 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement |
|
| November 8, 2023 |
Reimagining Mental Health Q3 2023 Earnings Presentation • November 8, 2023 Exhibit 99. |
|
| November 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40478 LifeStance Health Group, Inc. |
|
| November 8, 2023 |
LifeStance Reports Third Quarter 2023 Results Exhibit 99.1 Investor Relations Contact Monica Prokocki VP of Investor Relations 602-767-2100 [email protected] LifeStance Reports Third Quarter 2023 Results SCOTTSDALE, Ariz. – November 8, 2023 – LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the third quarter ended Septembe |
|
| November 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 08, 2023 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Co |
|
| October 5, 2023 |
LifeStance Health Group, Inc. 4800 N. Scottsdale Road Suite 6000 Scottsdale, Arizona 85251 LifeStance Health Group, Inc. 4800 N. Scottsdale Road Suite 6000 Scottsdale, Arizona 85251 October 5, 2023 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F. Street, N.E. Washington, D.C. 20549 Attention: Kristin Lochhead Brian Cascio Re: LifeStance Health Group, Inc. Form 10-K for the Fiscal Year Ended December 31, 20 |
|
| September 12, 2023 |
CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. §200.83 BY LIFESTANCE HEALTH GROUP, INC. LifeStance Health Group, Inc. 4800 N. Scottsdale Road Suite 6000 Scottsdale, Arizona 85251 FOIA Confidential Treatment Request The entity requesting confidential treatment is: LifeStance Health Group, Inc. 4800 N. Scottsdale Road Suite 6000 Scottsdale, AZ 85251 Attn: Ryan Pardo Chief Legal Officer September 1 |
|
| August 9, 2023 |
Reimagining Mental Health Q2 2023 Earnings Presentation • August 9, 2023 Exhibit 99. |
|
| August 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40478 LifeStance Health Group, Inc. |
|
| August 9, 2023 |
LifeStance Reports Second Quarter 2023 Results Exhibit 99.1 Investor Relations Contact Monica Prokocki VP of Investor Relations 602-767-2100 [email protected] LifeStance Reports Second Quarter 2023 Results SCOTTSDALE, Ariz. – August 9, 2023 – LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the second quarter ended June 30, |
|
| August 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 09, 2023 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Comm |
|
| June 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2023 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| May 10, 2023 |
LifeStance Reports First Quarter 2023 Results Exhibit 99.1 Investor Relations Contact Monica Prokocki VP of Investor Relations 602-767-2100 [email protected] LifeStance Reports First Quarter 2023 Results SCOTTSDALE, Ariz. – May 10, 2023 – LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the first quarter ended March 31, 20 |
|
| May 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40478 LifeStance Health Group, Inc. |
|
| May 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2023 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| May 10, 2023 |
Reimagining Mental Health Q1 2023 Earnings Presentation • May 10, 2023 Exhibit 99. |
|
| April 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin |
|
| April 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (a |
|
| March 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-40478 LifeStance Heal |
|
| March 9, 2023 |
Exhibit 10.32 TRANSITION AGREEMENT This Transition Agreement (this “Agreement”) is entered into by LifeStance Health Group, Inc. (“LifeStance”) LifeStance Health, Inc. (the “Company”, and collectively with LifeStance and its affiliates, the “Company Group”) and J. Michael Bruff (“Employee”) on November 2, 2022 (the “Signing Date”). RECITALS A. Employee and the Company Group have agreed to transiti |
|
| March 9, 2023 |
List of subsidiaries of LifeStance Health Group, Inc. Exhibit 21.1 Subsidiaries of the Registrant Entity Jurisdiction Subsidiaries of LifeStance Health Group, Inc. LifeStance TopCo, L.P. Delaware Subsidiaries of LifeStance TopCo, L.P. LifeStance Ultimate Holdings, Inc. Delaware Subsidiaries of LifeStance Ultimate Holdings, Inc. Lynnwood Intermediate Holdings, Inc. Delaware Subsidiaries of Lynnwood Intermediate Holdings, Inc. LifeStance Health Holding |
|
| March 9, 2023 |
Exhibit 10.30 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this “Agreement”), by and between LifeStance Health Group, Inc. (the “Company”), a Delaware corporation with its principal place of business in Scottsdale, Arizona, and David Bourdon (the “Executive”), is entered into as of November 2, 2022 and is effective as of the date the Executive actually commences employment with the Company (the |
|
| March 9, 2023 |
Exhibit 10.31 Name: David Bourdon Number of Shares of Common Stock subject to Award: 180,832 Date of Grant: November 10, 2022 LifeStance Health Group, Inc. 2021 Equity Incentive Plan Stock Award Agreement This agreement (this “Agreement”) evidences an award (the “Award”) of shares of Common Stock granted by LifeStance Health Group, Inc. (the “Company”) to the individual named above (the “Participa |
|
| March 9, 2023 |
As filed with the Securities and Exchange Commission on March 9, 2023 As filed with the Securities and Exchange Commission on March 9, 2023 Registration No. |
|
| March 9, 2023 |
Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) LifeStance Health Group, Inc. |
|
| March 9, 2023 |
Form of RSU Agreement (Time and Performance) (Sell to Cover) under the 2021 Plan Exhibit 10.29 Form of Performance-Based Award Name: [●] Number of Units subject to Award: [●] Date of Grant: [●] LifeStance Health Group, Inc. 2021 Equity Incentive Plan Time and Performance-Based Restricted Stock Unit Award Agreement This agreement (this “Agreement”) evidences an award (the “Award”) of restricted stock units granted by LifeStance Health Group, Inc. (the “Company”) to the individu |
|
| March 9, 2023 |
Form of RSU Agreement (Time) (Sell to Cover) under the 2021 Plan Exhibit 10.28 Form of Time-Based Award Name: [●] Number of Units subject to Award: [●] Date of Grant: [●] Vesting Commencement Date for RSUs: [●] LifeStance Health Group, Inc. 2021 Equity Incentive Plan Time and Performance-Based Restricted Stock Unit Award Agreement This agreement (this “Agreement”) evidences an award (the “Award”) of restricted stock units granted by LifeStance Health Group, Inc |
|
| March 9, 2023 |
Exhibit 10.34 LIFESTANCE HEALTH GROUP, INC. 2021 Equity Incentive Plan AMENDMENT TO Time-Based Restricted Stock Unit Award Agreement THIS AMENDMENT (this “Amendment”) amends the Time-Based Restricted Stock Unit Award Agreement (Time-Based Award) by and between LifeStance Health Group, Inc. (the “Company”) and J. Michael Bruff (the “Participant”), dated April 25, 2022 (as amended, the “Agreement”), |
|
| March 9, 2023 |
Exhibit 10.33 LIFESTANCE HEALTH GROUP, INC. AMENDMENT TO notice of amended award terms THIS AMENDMENT (this “Amendment”), effective as of November 2, 2022, amends that certain Notice of Amended Award Terms (the “Notice”), dated June 9, 2021, which describes certain amendments to the Partnership Interest Award Agreements (as amended and/or amended and restated from time to time, including as amende |
|
| March 8, 2023 |
Reimagining Mental Health Q4 2022 Earnings Presentation • March 8, 2023 Exhibit 99. |
|
| March 8, 2023 |
LifeStance Reports Fourth Quarter and Full Year 2022 Results Exhibit 99.1 Investor Relations Contact Monica Prokocki VP of Investor Relations 602-767-2100 [email protected] LifeStance Reports Fourth Quarter and Full Year 2022 Results SCOTTSDALE, Ariz. – March 8, 2023 – LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the fourth quarter a |
|
| March 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 08, 2023 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Commi |
|
| March 8, 2023 |
Second Amended and Restated Bylaws of LifeStance Health Group, Inc. Exhibit 3.1 SECOND AMENDED AND RESTATED BYLAWS OF LIFESTANCE HEALTH GROUP, INC. SECTION 1 - STOCKHOLDERS Section 1.1. Annual Meeting. An annual meeting of the stockholders of LifeStance Health Group, Inc., a Delaware corporation (the “Corporation”), for the election of directors to succeed those whose terms expire and for the transaction of such other business as may properly come before the meeti |
|
| February 13, 2023 |
LFST / LifeStance Health Group, Inc. / Lester Michael K. - SC 13G/A Passive Investment SC 13G/A 1 d444809dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* LifeStance Health Group, Inc. (Name of Issuer) Common stock, par value $0.01 per share (Title of Class of Securities) 53228F101 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement |
|
| November 9, 2022 |
Exhibit 10.7 LIFESTANCE HEALTH GROUP, INC. AMENDMENT TO notice of amended award terms THIS AMENDMENT (this ?Amendment?), effective as of September 7, 2022, amends that certain Notice of Amended Award Terms (the ?Notice?), dated June 9, 2021, which describes certain amendments to the Partnership Interest Award Agreement (as amended and/or amended and restated from time to time, including as amended |
|
| November 9, 2022 |
Exhibit 10.8 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this ?Agreement?), by and between LifeStance Health Group, Inc. (the ?Company?), a Delaware corporation with its principal place of business in Scottsdale, Arizona, and Kenneth Burdick (the ?Executive?), is entered into as of September 7, 2022 and is effective as of the date the Executive actually commences employment with the Company (t |
|
| November 9, 2022 |
Exhibit 10.1 SEPARATION AND GENERAL RELEASE AGREEMENT This Separation and Release of Claims Agreement (this ?Agreement?) is entered into by and among LifeStance Health Group, Inc. (?LifeStance?), LifeStance Health, Inc. (the ?Company?, and collectively with LifeStance and its affiliates, the ?Company Group?), Alert5 Consulting LLC (?Alert5?), a Washington limited liability company, and Michael K. |
|
| November 9, 2022 |
Form of Non-Qualified Stock Option Agreement Exhibit 10.10 Name: [ ] Number of Shares of Stock subject to the Stock Option: [ ] Exercise Price Per Share: [ ] Date of Grant: [ ] Vesting Commencement Date: [ ] lifestance health group, INC. 2021 Equity Incentive Plan Non-Statutory Stock Option Agreement This agreement (this ?Agreement?) evidences a stock option granted by LifeStance Health Group, Inc. (the ?Company?), to the individual named ab |
|
| November 9, 2022 |
Exhibit 10.3 LIFESTANCE HEALTH GROUP, INC. 2021 Equity Incentive Plan AMENDMENT TO Restricted Stock Unit Award Agreement THIS AMENDMENT (this ?Amendment?) amends the Restricted Stock Unit Award Agreement by and between LifeStance Health Group, Inc. (the ?Company?), and Michael Lester (the ?Participant?), dated June 9, 2021 (the ?Agreement?), and is effective as of September 7, 2022 (the ?Effective |
|
| November 9, 2022 |
Exhibit 10.4 AMENDMENT TO Stock Transfer Restriction Agreement THIS AMENDMENT TO THE Stock Transfer Restriction Agreement (this ?Amendment?) is made as of September 7, 2022, by and among LifeStance Health Group, Inc., a Delaware limited liability company (the ?Company?), TPG VIII Lynnwood Holdings Aggregation, L.P. (?TPG?), and Michael Lester ( ?Lester? and collectively with the Company and TPG, t |
|
| November 9, 2022 |
Exhibit 10.5 LIFESTANCE HEALTH GROUP, INC. 2021 Equity Incentive Plan AMENDMENT TO Time and Performance-Based Restricted Stock Unit Award Agreement (Time-Based Award) THIS AMENDMENT (this ?Amendment?) amends the Time and Performance-Based Restricted Stock Unit Award Agreement (Time-Based Award) by and between LifeStance Health Group, Inc. (the ?Company?) and Michael Lester (the ?Participant?), dat |
|
| November 9, 2022 |
Exhibit 10.2 LifeStance Health Group, Inc. CONSULTING AGREEMENT This CONSULTING Agreement (this ?Agreement?), made and entered into as of September 8, 2022 (the ?Effective Date?), among LifeStance Health Group, Inc. (?Company?), on the one hand, and Alert5 Consulting LLC (?Contractor?), a Washington limited liability company, and Michael K. Lester (?Lester?), on the other hand, contains the terms |
|
| November 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40478 LifeStance Health Group, Inc. |
|
| November 9, 2022 |
Letter Agreement, dated September 7, 2022, between LifeStance Health Group, Inc. and Danish Qureshi Exhibit 10.9 September 7, 2022 Dear Danish, Congratulations! As we have discussed, beginning on September 7, 2022 (the ?Promotion Date?), you will serve as President of LifeStance Health Group, Inc. (the ?Company?), in addition to your role as Chief Operating Officer. In connection with this promotion, and in consideration of your enhanced role with the Company, you will receive an increase in you |
|
| November 9, 2022 |
Exhibit 10.6 LIFESTANCE HEALTH GROUP, INC. 2021 Equity Incentive Plan AMENDMENT TO Time and Performance-Based Restricted Stock Unit Award Agreement (Performance-Based Award) THIS AMENDMENT (this ?Amendment?) amends the Time and Performance-Based Restricted Stock Unit Award Agreement (Performance-Based Award) by and between LifeStance Health Group, Inc. (the ?Company?) and Michael Lester (the ?Part |
|
| November 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 08, 2022 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Co |
|
| November 8, 2022 |
LifeStance Reports Third Quarter 2022 Results Exhibit 99.1 Investor Relations Contact Monica Prokocki VP of Investor Relations 602-767-2100 [email protected] LifeStance Reports Third Quarter 2022 Results SCOTTSDALE, Ariz. ? November 8, 2022 ? LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation?s largest providers of outpatient mental healthcare, today announced financial results for the quarter ended September 30, |
|
| November 8, 2022 |
Q3 2022 Earnings Presentation November 8, 2022 Exhibit 99.2 Forward-Looking Statements 2 DISCLAIMERS Cautionary Note Regarding Forward-Looking Statements This presentation and related oral statements, including during any question and answer portion of the presentation, contain forward-looking statements about LifeStance Health Group, Inc. and its subsidiaries (?LifeStance?) and the industry in wh |
|
| November 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2022 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Com |
|
| November 3, 2022 |
Exhibit 99.1 LIFESTANCE HEALTH APPOINTS J. MICHAEL BRUFF AS NEW BUSINESS TRANFORMATION OFFICER; DAVID BOURDON AS CHIEF FINANCIAL OFFICER SCOTTSDALE, Ariz. - Nov. 3, 2022 ? LifeStance Health (NASDAQ: LFST), one of the nation?s largest providers of outpatient mental healthcare, today announced that effective November 10, 2022, J. Michael Bruff, currently Chief Financial Officer, will take on a new r |
|
| September 8, 2022 |
Exhibit 99.1 Press Release LifeStance Health Appoints Ken Burdick as CEO and Chairman; Founding CEO and Chairman Michael Lester Retires Danish Qureshi Named President in Addition to Role as Chief Operating Officer SCOTTSDALE, Ariz., September 8, 2022 ? LifeStance Health (NASDAQ: LFST), one of the nation?s largest providers of in-person and virtual outpatient mental healthcare, today announced that |
|
| September 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 7, 2022 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Co |
|
| August 10, 2022 |
Exhibit 10.1 Execution Version CREDIT AGREEMENT Dated as of May 4, 2022 among LIFESTANCE HEALTH HOLDINGS, INC., as the Borrower, LYNNWOOD INTERMEDIATE HOLDINGS, INC., as Holdings, CAPITAL ONE, NATIONAL ASSOCIATION as Administrative Agent, Collateral Agent, Revolver Agent, Issuing Bank and Swing Line Lender, and THE OTHER LENDERS PARTY HERETO Table of Contents Page Article I Definitions and Account |
|
| August 10, 2022 |
Severance and Change in Control Policy Exhibit 10.6 LIFESTANCE HEALTH GROUP, INC. SEVERANCE AND CHANGE IN CONTROL POLICY This Severance and Change in Control Policy (this ?Policy?) of LifeStance Health Group, Inc. (the ?Company?), effective as of August 5, 2022 (the ?Effective Date?), sets forth the payments and benefits the Company intends to provide to certain employees of the Company and its subsidiaries who have been selected for p |
|
| August 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40478 LifeStance Health Group, Inc. |
|
| August 10, 2022 |
Exhibit 10.3 LifeStance Health Group, Inc. INDEPENDENT CONTRACTOR AGREEMENT This INDEPENDENT Contractor Agreement (this ?Agreement?), made and entered into as of July 1, 2022 (the ?Effective Date?), between LifeStance Health Group, Inc. (?Company?) and Gwendolyn Booth (?Contractor?) contains the terms and conditions on which Contractor will provide certain Services (as hereinafter defined) to Comp |
|
| August 10, 2022 |
Exhibit 10.5 AMENDMENT TO Stock Transfer Restriction Agreement THIS AMENDMENT TO THE Stock Transfer Restriction Agreement (this ?Amendment?) is made as of June 30, 2022, by and among LifeStance Health Group Inc., a Delaware limited liability company (the ?Company?), TPG VIII Lynwood Holdings Aggregation, L.P. (?TPG?), and Gwendolyn Booth ( ?Booth? and collectively with the Company and TPG, the ?Pa |
|
| August 10, 2022 |
Exhibit 10.4 LIFESTANCE HEALTH GROUP, INC. 2021 Equity Incentive Plan AMENDMENT TO Restricted Stock Unit Award Agreement THIS AMENDMENT (this ?Amendment?) amends the Restricted Stock Unit Award Agreement by and between LifeStance Health Group, Inc. (the ?Company?), and Gwendolyn Booth (the ?Participant?), dated June 9, 2021 (the ?Agreement?), and is made as of June 30, 2022. Any capitalized term n |
|
| August 10, 2022 |
Exhibit 10.2 SEPARATION AND GENERAL RELEASE AGREEMENT This Separation and Release of Claims Agreement (this ?Agreement?) is entered into by LifeStance Health Group, Inc. (?LifeStance?), and Gwendolyn Booth (?Employee?). RECITALS A. Prior to June 30, 2022, Employee was employed by LifeStance; B. Employee and LifeStance have agreed to terminate Employee?s employment with LifeStance effective at the |
|
| August 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 09, 2022 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Comm |
|
| August 9, 2022 |
LifeStance Reports Second Quarter 2022 Results Exhibit 99.1 Investor Relations Contact Monica Prokocki VP of Investor Relations 602-767-2100 [email protected] LifeStance Reports Second Quarter 2022 Results SCOTTSDALE, Ariz. ? August 9, 2022 ? LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation?s largest providers of outpatient mental health care, today announced financial results for the quarter ended June 30, 2022. |
|
| August 9, 2022 |
Q2 2022 Earnings Presentation August 9, 2022 Exhibit 99.2 Forward-Looking Statements 2 DISCLAIMERS Cautionary Note Regarding Forward-Looking Statements This presentation and related oral statements contain forward-looking statements about LifeStance Health Group, Inc. and its subsidiaries (?LifeStance?) and the industry in which LifeStance operates, including statements regarding full-year and thi |
|
| June 2, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2022 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| May 24, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 24, 2022 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| May 23, 2022 |
Exhibit 99.1 LIFESTANCE HEALTH NAMES DANISH QURESHI AS CHIEF OPERATING OFFICER, EFFECTIVE JULY 1, 2022 Gwen Booth Retiring from COO Role; Appointed as Executive Director, LifeStance Health Foundation SCOTTSDALE, Ariz.?May 23, 2022?LifeStance Health (NASDAQ: LFST), one of the nation?s largest providers of outpatient mental healthcare, today announced that its Board of Directors approved the appoint |
|
| May 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2022 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| May 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40478 LifeStance Health Group, Inc. |
|
| May 9, 2022 |
LifeStance Reports First Quarter 2022 Results Exhibit 99.1 Investor Relations Contact Monica Prokocki VP of Investor Relations 602-767-2100 [email protected] LifeStance Reports First Quarter 2022 Results SCOTTSDALE, Ariz. ? May 9, 2022 ? LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation?s largest providers of outpatient mental health care, today announced financial results for the quarter ended March 31, 2022. (A |
|
| May 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 04, 2022 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| May 9, 2022 |
Q1 2022 Earnings Presentation May 9, 2022 Exhibit 99.2 Forward-Looking Statements DISCLAIMERS Cautionary Note Regarding Forward-Looking Statements This presentation and related oral statements contain forward-looking statements about LifeStance Health Group, Inc. and its subsidiaries (?LifeStance?) and the industry in which LifeStance operates, including statements regarding full-year and second q |
|
| April 21, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ????Preliminary Proxy Statement ????Confidential, for Use of the Commission Only (as permitted by Rul |
|
| April 21, 2022 |
DEFA14A 1 d290417ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange ACT of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confident |
|
| March 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-40478 LifeStance Heal |
|
| March 17, 2022 |
Exhibit 4.2 Description of Capital Stock General The following description of our capital stock is intended as a summary only and is qualified in its entirety by reference to our certificate of incorporation and bylaws, which are filed as exhibits to the Annual Report on Form 10-K of which this Exhibit 4.2 is a part, and to the applicable provisions of the Delaware General Corporation Law (the ?DG |
|
| March 17, 2022 |
List of subsidiaries of LifeStance Health Group, Inc. Exhibit 21.1 Subsidiaries of the Registrant Entity Jurisdiction Subsidiaries of LifeStance Health Group, Inc. LifeStance TopCo, L.P. Delaware Subsidiaries of LifeStance TopCo, L.P. LifeStance Ultimate Holdings, Inc. Delaware Subsidiaries of LifeStance Ultimate Holdings, Inc. Lynnwood Intermediate Holdings, Inc. Delaware Subsidiaries of Lynnwood Intermediate Holdings, Inc. LifeStance Health Holding |
|
| March 17, 2022 |
EX-FILING FEES 4 d329183dexfilingfees.htm EX-FILING FEES Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) LifeStance Health Group, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee |
|
| March 17, 2022 |
As filed with the Securities and Exchange Commission on March 17, 2022 S-8 1 d329183ds8.htm S-8 As filed with the Securities and Exchange Commission on March 17, 2022 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT under the SECURITIES ACT OF 1933 LifeStance Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 86-1832801 ( State or Other Jurisdiction of Incorpo |
|
| March 17, 2022 |
Exhibit 10.4 Execution Version THIRD AMENDMENT TO CREDIT AGREEMENT This THIRD AMENDMENT TO CREDIT AGREEMENT (this ?Amendment?) dated as of April 30, 2021 by and among LifeStance Health Holdings, Inc., a Delaware corporation (the ?Borrower?), Lynnwood Intermediate Holdings, Inc. (?Holdings?), Capital One, National Association (?Capital One?), as administrative agent and as collateral agent (in each |
|
| March 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 10, 2022 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Commi |
|
| March 10, 2022 |
LifeStance Reports Fourth Quarter and Full Year 2021 Results Exhibit 99.1 Investor Relations Contact Monica Prokocki VP of Investor Relations 602-767-2100 [email protected] LifeStance Reports Fourth Quarter and Full Year 2021 Results SCOTTSDALE, Ariz. ? March 10, 2022 ? LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation?s largest providers of outpatient mental health care, today announced financial results for the fourth quarter |
|
| March 10, 2022 |
Q4 2021 Earnings Presentation March 10, 2022 Exhibit 99.2 Forward-Looking Statements DISCLAIMERS Cautionary Note Regarding Forward-Looking Statements This presentation and related oral statements contain forward-looking statements about LifeStance Health Group, Inc. and its subsidiaries (?LifeStance?) and the industry in which LifeStance operates, including statements regarding full-year and first |
|
| February 18, 2022 |
LFST / LifeStance Health Group, Inc. / Lester Michael K. - SC 13G Passive Investment SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* LifeStance Health Group, Inc. (Name of Issuer) Common stock, par value $0.001 per share (Title of Class of Securities) 53228F101 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to d |
|
| February 14, 2022 |
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13G Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13G The undersigned hereby agree as follows: (i) Each of them is individually eligible to use the Schedule 13G to which this Exhibit is attached, and such Schedule 13G is filed on behalf of each of them; and (ii) Each of them is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate. |
|
| February 14, 2022 |
LFST / LifeStance Health Group, Inc. / Silversmith Partners I GP, LLC - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* LifeStance Health Group, Inc. (Name of Issuer) Common stock, par value $0.001 per share (Title of Class of Securities) 53228F101 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designat |
|
| February 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. )* Under the Securities Exchange Act of 1934 LifeStance Health Group, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Titles of Class of Securities) 53228F101 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designat |
|
| February 4, 2022 |
EXHIBIT A JOINT FILING AGREEMENT This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the shares of Common Stock, par value $0. |
|
| February 4, 2022 |
LFST / LifeStance Health Group, Inc. / SUMMIT PARTNERS L P - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )* LifeStance Health Group, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 53228F101 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the Appropriate Box to Designate |
|
| February 4, 2022 |
EXHIBIT B POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Adam H. |
|
| November 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40478 LifeStance Health Group, Inc. |
|
| November 8, 2021 |
LifeStance Reports Third Quarter 2021 Results Exhibit 99.1 Investor Relations Contact Monica Prokocki VP of Investor Relations 602-767-2100 [email protected] LifeStance Reports Third Quarter 2021 Results Third Quarter 2021 Highlights (All results compared to prior-year comparative period, unless otherwise noted) ? Revenue of $173.8 million increased $71.8 million or 70% compared to revenue of $102.0 million ? Total clinicians |
|
| November 8, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 08, 2021 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Co |
|
| November 8, 2021 |
Q3 2021 Earnings Presentation November 8, 2021 Exhibit 99.2 Forward-Looking Statements DISCLAIMERS Cautionary Note Regarding Forward-Looking Statements This presentation contains forward-looking statements about LifeStance Health Group, Inc. and its subsidiaries (?LifeStance?) and the industry in which LifeStance operates, including statements regarding future results of operations and financial p |
|
| August 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 22, 2021 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Comm |
|
| August 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q xx UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40478 LifeStance Health Group, Inc. |
|
| August 11, 2021 |
LifeStance Health Reports Second Quarter 2021 Results Exhibit 99.1 Investor Relations Contact Monica Prokocki VP of Investor Relations 425-279-8500 [email protected] LifeStance Health Reports Second Quarter 2021 Results Second Quarter 2021 Highlights ? Revenue of $160.5 million increased $76.5 million or 91%1 compared to revenue of $38.6 million for the period from April 1, 2020 to May 14, 2020 (Predecessor) and $45.4 million for the p |
|
| August 11, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2021 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Comm |
|
| August 11, 2021 |
Q2 2021 Earnings Presentation August 11, 2021 Exhibit 99.2 Forward-Looking Statements DISCLAIMERS Cautionary Note Regarding Forward-Looking Statements This presentation contains forward-looking statements about LifeStance Health Group, Inc. and its subsidiaries (?LifeStance?) and the industry in which LifeStance operates, including statements regarding future results of operations and financial po |
|
| June 15, 2021 |
Amended and Restated Bylaws of LifeStance Health Group, Inc. EX-3.2 3 d176095dex32.htm EX-3.2 Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF LIFESTANCE HEALTH GROUP, INC. SECTION 1 - STOCKHOLDERS Section 1.1. Annual Meeting. An annual meeting of the stockholders of LifeStance Health Group, Inc., a Delaware corporation (the “Corporation”), for the election of directors to succeed those whose terms expire and for the transaction of such other business as may prop |
|
| June 15, 2021 |
8-K 1 d176095d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 9, 2021 LifeStance Health Group, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40478 86-1832801 (State or other jurisdiction o |
|
| June 15, 2021 |
LifeStance Health Group, Inc. 2021 Employee Stock Purchase Plan EX-10.5 8 d176095dex105.htm EX-10.5 Exhibit 10.5 LIFESTANCE HEALTH GROUP, INC. 2021 EMPLOYEE STOCK PURCHASE PLAN 1. DEFINED TERMS Exhibit A, which is incorporated by reference, defines the terms used in the Plan and sets forth certain operational rules related to those terms. 2. PURPOSE The Plan is intended to enable Eligible Employees to use payroll deductions to purchase shares of Stock in offer |
|
| June 15, 2021 |
Amended and Restated Certificate of Incorporation of LifeStance Health Group, Inc. Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF LIFESTANCE HEALTH GROUP, INC. LifeStance Health Group, Inc., a Delaware corporation (the ?Corporation?), hereby certifies that this Amended and Restated Certificate of Incorporation has been duly adopted in accordance with Sections 242 and 245 of the General Corporation Law of the State of Delaware (the ?DGCL?), and that: A. The name |
|
| June 15, 2021 |
LifeStance Health Group, Inc. 2021 Equity Incentive Plan EX-10.4 7 d176095dex104.htm EX-10.4 Exhibit 10.4 LIFESTANCE HEALTH GROUP, INC. 2021 EQUITY INCENTIVE PLAN 1. DEFINED TERMS Exhibit A, which is incorporated by reference, defines certain terms used in the Plan and includes certain operational rules related to those terms. 2. PURPOSE The Plan has been established to advance the interests of the Company by providing for the grant to Participants of S |
|
| June 15, 2021 |
Exhibit 10.2 This STOCKHOLDERS AGREEMENT (as it may be amended from time to time in accordance with the terms hereof, this ?Agreement?), dated as of June 9, 2021, is made by and among: a. LifeStance Health Group, Inc., a Delaware corporation (the ?Company?); b. TPG VIII Lynnwood Holdings Aggregation, L.P., a Delaware limited partnership (?TPG? and, collectively with its Permitted Transferees that |
|
| June 15, 2021 |
EX-10.3 6 d176095dex103.htm EX-10.3 Exhibit 10.3 STOCK TRANSFER RESTRICTION AGREEMENT This Stock Transfer Restriction Agreement (the “Agreement”) is made as of June 9, 2021 by and among LifeStance Health Group, Inc., a Delaware corporation (the “Company”); LifeStance TopCo, L.P., a Delaware limited partnership (the “Partnership”); the Sponsor Investors (as defined herein); the Management Investors |
|
| June 15, 2021 |
EX-10.1 4 d176095dex101.htm EX-10.1 Exhibit 10.1 REGISTRATION RIGHTS AGREEMENT BY AND AMONG LIFESTANCE HEALTH GROUP, INC. AND THE STOCKHOLDERS PARTY HERETO DATED AS OF JUNE 9, 2021 TABLE OF CONTENTS Page ARTICLE I EFFECTIVENESS 2 Section 1.1. Effectiveness 2 ARTICLE II DEFINITIONS 2 Section 2.1. Definitions 2 Section 2.2. Other Interpretive Provisions 7 ARTICLE III REGISTRATION RIGHTS 7 Section 3. |
|
| June 15, 2021 |
LifeStance Health Group, Inc. 2021 Cash Incentive Plan EX-10.6 9 d176095dex106.htm EX-10.6 Exhibit 10.6 LIFESTANCE HEALTH GROUP, INC. 2021 CASH INCENTIVE PLAN 1. DEFINED TERMS Exhibit A, which is incorporated by reference, defines certain terms used in the Plan and sets forth operational rules related to those terms. 2. PURPOSE The Plan has been established to advance the interests of the Company by providing for the grant of cash-based incentive Awar |
|
| June 14, 2021 |
As filed with the Securities and Exchange Commission on June 14, 2021 Registration No. |
|
| June 11, 2021 |
Table of Contents Filed Pursuant to Rule 424(b)(4) Registration No. 333-256202 Prospectus 40,000,000 shares LifeStance Health Group, Inc. Common stock $18.00 per share This is the initial public offering of our common stock. We are offering 32,800,000 shares of our common stock and the selling stockholders are offering an additional 7,200,000 shares of our common stock. We will not receive any of |
|
| June 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A For Registration of Certain Classes of Securities Pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934 LIFESTANCE HEALTH GROUP, INC. (Exact name of registrant as specified in its charter) Delaware 86-1832801 (State of Incorporation) (I.R.S. Employer Identification No.) 4800 N. Scottsdale Road, Suite |
|
| June 8, 2021 |
Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 Goldman Sachs & Co. LLC 200 West Street New York, New York 10282 J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 10179 Jefferies LLC 520 Madison Avenue New York, New York 10022 June 8, 2021 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: L |
|
| June 8, 2021 |
As filed with the Securities and Exchange Commission on June 8, 2021 Table of Contents As filed with the Securities and Exchange Commission on June 8, 2021 Registration No. |
|
| June 8, 2021 |
LifeStance Health Group, Inc. 4800 N. Scottsdale Road, Suite 6000 Scottsdale, AZ 85251 LifeStance Health Group, Inc. 4800 N. Scottsdale Road, Suite 6000 Scottsdale, AZ 85251 June 8, 2021 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Deanna Virginio; Jeffrey Gabor Re: LifeStance Health Group, Inc. Registration Statement on Form S-1 (File No. 333-256202) Request for Acceleration Ladies and Gentlemen: P |
|
| June 8, 2021 |
ROPES & GRAY LLP PRUDENTIAL TOWER 800 BOYLSTON STREET BOSTON, MA 02199-3600 WWW.ROPESGRAY.COM June 8, 2021 BY EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Tracie Mariner; Brian Cascio Deanna Virginio; Jeffrey Gabor Re: LifeStance Health Group, Inc. Amendment No. 1 to Registration Statement on Form S-1 Filed June 1, 20 |
|
| June 1, 2021 |
As filed with the Securities and Exchange Commission on June 1, 2021 Table of Contents As filed with the Securities and Exchange Commission on June 1, 2021 Registration No. |
|
| June 1, 2021 |
Form of Registration Rights Agreement Exhibit 4.2 FORM OF REGISTRATION RIGHTS AGREEMENT BY AND AMONG LIFESTANCE HEALTH GROUP, INC. AND THE STOCKHOLDERS PARTY HERETO DATED AS OF JUNE [ ], 2021 TABLE OF CONTENTS Page ARTICLE I EFFECTIVENESS 2 Section 1.1. Effectiveness 2 ARTICLE II DEFINITIONS 2 Section 2.1. Definitions 2 Section 2.2. Other Interpretive Provisions 7 ARTICLE III REGISTRATION RIGHTS 7 Section 3.1. Demand Registration 7 Se |
|
| June 1, 2021 |
Form of Underwriting Agreement EX-1.1 2 d112007dex11.htm EX-1.1 Exhibit 1.1 [ ] SHARES LIFESTANCE HEALTH GROUP, INC. COMMON STOCK, PAR VALUE $0.01 PER SHARE UNDERWRITING AGREEMENT June [ ], 2021 Morgan Stanley & Co. LLC Goldman Sachs & Co. LLC J.P. Morgan Securities LLC Jefferies LLC As representatives of the several Underwriters listed in Schedule I hereto c/o Morgan Stanley & Co. LLC 1585 Broadway New York, NY 10036 c/o Goldm |
|
| June 1, 2021 |
Exhibit 10.14 LIFESTANCE HEALTH GROUP, INC. 2021 EMPLOYEE STOCK PURCHASE PLAN 1. DEFINED TERMS Exhibit A, which is incorporated by reference, defines the terms used in the Plan and sets forth certain operational rules related to those terms. 2. PURPOSE The Plan is intended to enable Eligible Employees to use payroll deductions to purchase shares of Stock in offerings under the Plan, and thereby ac |
|
| June 1, 2021 |
Form of Notice of Amended Award Terms for Class B Unit Award Agreement Exhibit 10.13 May [ ], 2021 LIFESTANCE TOPCO, L.P. NOTICE OF AMENDED AWARD TERMS This notice (this ?Notice?) describes certain amendments that are being made to the Partnership Interest Award Agreement[s] (as amended and/or amended and restated from time to time, your ?Award Agreement[s]?) between you and LifeStance TopCo, L.P. (the ?Partnership?) and to any Class B Units you received under such A |
|
| June 1, 2021 |
Exhibit 10.1 Execution Version CREDIT AGREEMENT Dated as of May 14, 2020 among LYNNWOOD MERGERSUB, INC., as the Initial Borrower, which on the Closing Date shall be merged with and into, LIFESTANCE HEALTH HOLDINGS, INC., with LifeStance Health Holdings, Inc. surviving such merger as the Borrower, LYNNWOOD INTERMEDIATE HOLDINGS, INC., as Holdings, CAPITAL ONE, NATIONAL ASSOCIATION, as Administrativ |
|
| June 1, 2021 |
LifeStance Health Group, Inc. 2021 Cash Incentive Plan EX-10.15 15 d112007dex1015.htm EX-10.15 Exhibit 10.15 LIFESTANCE HEALTH GROUP, INC. 2021 CASH INCENTIVE PLAN 1. DEFINED TERMS Exhibit A, which is incorporated by reference, defines certain terms used in the Plan and sets forth operational rules related to those terms. 2. PURPOSE The Plan has been established to advance the interests of the Company by providing for the grant of cash-based incentive |
|
| June 1, 2021 |
EX-3.1 3 d112007dex31.htm EX-3.1 Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF LIFESTANCE HEALTH GROUP, INC. LifeStance Health Group, Inc., a Delaware corporation (the “Corporation”), hereby certifies that this Amended and Restated Certificate of Incorporation has been duly adopted in accordance with Sections 242 and 245 of the General Corporation Law of the State of Delaware (t |
|
| June 1, 2021 |
Subsidiaries of the Registrant Exhibit 21.1 Subsidiaries of the Registrant Entity Jurisdiction Subsidiaries of LifeStance TopCo, LP LifeStance Ultimate Holdings, Inc. Delaware Subsidiaries of LifeStance Ultimate Holdings, Inc. Lynnwood Intermediate Holdings, Inc. Delaware Subsidiaries of Lynnwood Intermediate Holdings, Inc. LifeStance Health Holdings, Inc. Delaware Subsidiaries of LifeStance Health Holdings, Inc. LifeStance Hea |
|
| June 1, 2021 |
Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF LIFESTANCE HEALTH GROUP, INC. SECTION 1 - STOCKHOLDERS Section 1.1. Annual Meeting. An annual meeting of the stockholders of LifeStance Health Group, Inc., a Delaware corporation (the ?Corporation?), for the election of directors to succeed those whose terms expire and for the transaction of such other business as may properly come before the meeting shal |
|
| June 1, 2021 |
ROPES & GRAY LLP PRUDENTIAL TOWER 800 BOYLSTON STREET BOSTON, MA 02199-3600 WWW.ROPESGRAY.COM June 1, 2021 BY EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Tracie Mariner; Brian Cascio Deanna Virginio; Jeffrey Gabor Re: LifeStance Health Group, Inc. Registration Statement on Form S-1 Submitted May 17, 2021 CIK No. 0001 |
|
| June 1, 2021 |
Exhibit 10.11 LIFESTANCE HEALTH GROUP, INC. 2021 EQUITY INCENTIVE PLAN 1. DEFINED TERMS Exhibit A, which is incorporated by reference, defines certain terms used in the Plan and includes certain operational rules related to those terms. 2. PURPOSE The Plan has been established to advance the interests of the Company by providing for the grant to Participants of Stock and Stock-based Awards. 3. ADM |
|
| June 1, 2021 |
Exhibit 10.20 FORM OF AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this ?Agreement?) is made and entered into as of June [ ], 2021, by and among LFST Merger Sub, LLC, a Delaware limited liability company (?Merger Sub?), LifeStance TopCo, L.P., a Delaware limited partnership (?TopCo?), LifeStance Health Group, Inc., a Delaware corporation (?PubCo?), in accordance with Section 18- |
|
| June 1, 2021 |
Exhibit 10.19 FORM OF LIMITED PARTNER CONTRIBUTION AND EXCHANGE AGREEMENT BY AND AMONG LIFESTANCE HEALTH GROUP, INC., LIFESTANCE TOPCO, L.P. AND THE LIMITED PARTNERS OF LIFESTANCE TOPCO, L.P. PARTY HERETO DATED AS OF JUNE [ ], 2021 1 This LIMITED PARTNER CONTRIBUTION AND EXCHANGE AGREEMENT (this ?Agreement?), dated as of June [ ], 2021, is hereby entered into by and among LifeStance Health Group, |
|
| June 1, 2021 |
Form of Stockholders Agreement Exhibit 10.4 FORM OF STOCKHOLDERS AGREEMENT BY AND AMONG LIFESTANCE HEALTH GROUP, INC. AND THE STOCKHOLDERS PARTY HERETO DATED AS OF JUNE [ ], 2021 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 2 Section 1.1.??Definitions 2 Section 1.2.??Other Interpretive Provisions 4 ARTICLE II REPRESENTATIONS AND WARRANTIES 5 Section 2.1.??Existence; Authority; Enforceability 5 Section 2.2.??Absence of Conflicts |
|
| June 1, 2021 |
Form of Common Stock Certificate Exhibit 4.1 NUMBER SHARES COMMON STOCK INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP 53228F 10 1 this Certifies that: SPECIMEN?NOT NEGOTIABLE is the owner of FULLY PAID AND NON-ASSESSABLE SHARES OF COMMON STOCK OF $0.01 PAR VALUE EACH OF AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC COUNTERSIGNED AND REGISTERED: BROOKLYN, NY LifeStance HeaLtH Group, |
|
| June 1, 2021 |
Form of Stock Transfer Restriction Agreement Exhibit 10.5 FORM OF STOCK TRANSFER RESTRICTION AGREEMENT This Stock Transfer Restriction Agreement (the ?Agreement?) is made as of June [ ], 2021 by and among LifeStance Health Group, Inc., a Delaware corporation (the ?Company?); LifeStance TopCo, L.P., a Delaware limited partnership (the ?Partnership?); the Sponsor Investors (as defined herein); the Management Investors (as defined herein); and |
|
| June 1, 2021 |
Form of RSU Agreement under the 2021 Plan Exhibit 10.12 Name: [ ] Number of Restricted Stock Units subject to Award: [ ] Date of Grant: [ ] LIFESTANCE HEALTH GROUP, INC. 2021 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT This agreement (this ?Agreement?) evidences an award (the ?Award?) of restricted stock units granted by LifeStance Health Group, Inc. (the ?Company?) to the individual named above (the ?Participant?), pursua |
|
| May 18, 2021 |
ROPES & GRAY LLP PRUDENTIAL TOWER 800 BOYLSTON STREET BOSTON, MA 02199-3600 WWW.ROPESGRAY.COM CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. ?200.83 BY LIFESTANCE HEALTH GROUP, INC. CONTACT: RYAN PARDO, CHIEF LEGAL OFFICER OF LIFESTANCE HEALTH GROUP, INC. AT (425) 279-8500 FOIA Confidential Treatment Request The entity requesting confidential treatment is: LifeStance Health Group, Inc. 4800 N. S |
|
| May 17, 2021 |
Exhibit 10.8 AMENDED AND RESTATED EMPLOYMENT AGREEMENT This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this ?Agreement?), by and between LifeStance Health, Inc. (the ?Company?), a Delaware corporation with its principal place of business in Bellevue, Washington, and Gwendolyn H. Booth (the ?Executive?), is entered into as of May 14, 2020 (the ?Effective Date?). W I T N E S S E T H WHEREAS, the Com |
|
| May 17, 2021 |
Power of Attorney (included in the signature pages to this Registration Statement) Table of Contents As filed with the Securities and Exchange Commission on May 17, 2021 Registration No. |
|
| May 17, 2021 |
Form of Class B Unit Award Agreement EX-10.18 11 d112007dex1018.htm EX-10.18 Exhibit 10.18 LYNWOOD TOPCO, L.P. FORM OF CLASS B UNIT AWARD AGREEMENT This Partnership Interest Award Agreement (this “Agreement”) is made effective as of [•] (the “Date of Grant”), by and between Lynwood TopCo, L.P., a Delaware limited partnership (the “Partnership”), and [•] (the “Participant”). Certain capitalized terms used in this Agreement are defined |
|
| May 17, 2021 |
Exhibit 10.10 INDEPENDENT CONSULTING AGREEMENT This INDEPENDENT CONSULTING AGREEMENT (this ?Agreement?) is made and entered into effective as of June 1, 2020 (the ?Effective Date?), by and among LifeStance Health, Inc. (?LifeStance?), a Delaware corporation, on the one hand, and Alert5 Consulting LLC (?Alert5?). a Washington limited liability company, and (with respect to Sections 2(a), 5 through |
|
| May 17, 2021 |
EX-10.9 8 d112007dex109.htm EX-10.9 Exhibit 10.9 AMENDED AND RESTATED EMPLOYMENT AGREEMENT This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”), by and between LifeStance Health, Inc. (the “Company”), a Delaware corporation with its principal place of business in Bellevue, Washington, and Danish Qureshi (the “Executive”), is entered into as of May 14, 2020 (the “Effective Date”). W I |
|
| May 17, 2021 |
Exhibit 10.2 Execution Version FIRST AMENDMENT TO CREDIT AGREEMENT This FIRST AMENDMENT TO CREDIT AGREEMENT (this ?Amendment?) dated as of November 4, 2020 by and among LifeStance Health Holdings, Inc., a Delaware corporation (the ?Borrower?), Lynnwood Intermediate Holdings, Inc. (?Holdings?), Capital One, National Association (?Capital One?), as administrative agent and as collateral agent (in ea |
|
| May 17, 2021 |
Form of Management Services Agreement with Affiliated Practices EX-10.19 12 d112007dex1019.htm EX-10.19 Exhibit 10.19 FORM OF MANAGEMENT SERVICES AGREEMENT THIS MANAGEMENT SERVICES AGREEMENT (this “Agreement”), effective as of [DATE], the (“Effective Date”), is entered into by and between Behavioral Health Practice Services, LLC (the “Company”) and [ENTITY NAME], a [ENTITY TYPE] (the “Practice”) (the Company and the Practice shall be collectively referred to a |
|
| May 17, 2021 |
EX-10.1 2 d112007dex101.htm EX-10.1 Exhibit 10.1 Execution Version CREDIT AGREEMENT Dated as of May 14, 2020 among LYNNWOOD MERGERSUB, INC., as the Initial Borrower, which on the Closing Date shall be merged with and into, LIFESTANCE HEALTH HOLDINGS, INC., with LifeStance Health Holdings, Inc. surviving such merger as the Borrower, LYNNWOOD INTERMEDIATE HOLDINGS, INC., as Holdings, CAPITAL ONE, NA |
|
| May 17, 2021 |
EX-10.6 5 d112007dex106.htm EX-10.6 Exhibit 10.6 AMENDED AND RESTATED EMPLOYMENT AGREEMENT This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”), by and between LifeStance Health, Inc. (the “Company”), a Delaware corporation with its principal place of business in Bellevue, Washington, and Michael K. Lester (the “Executive”), is entered into as of May 14, 2020 (the “Effective Date”). W |
|
| May 17, 2021 |
EX-10.17 10 d112007dex1017.htm EX-10.17 Exhibit 10.17 FORM OF INDEMNIFICATION AGREEMENT This Indemnification Agreement (this “Agreement”) is made and entered into as of [•], 2021, by and among LifeStance Health Group, Inc., a Delaware corporation (the “Company”), and [NAME OF DIRECTOR/OFFICER] (“Indemnitee”). WHEREAS, in light of the litigation costs and risks to directors and officers resulting f |
|
| May 17, 2021 |
Exhibit 16.1 CliftonLarsonAllen LLP 10700 Northup Way Suite 200 Bellevue, WA 98004 425-250-6100 | Fax 425-250-6050 www.cliftonlarsonallen.com May 12, 2021 Securities and Exchange Commission Washington, D.C. 20549 We have read the statements that LifeStance Health Group, Inc. (?LifeStance?) made under ?Changes in Independent Registered Public Accounting Firm? of the Form S-1 that LifeStance filed o |
|
| May 17, 2021 |
Exhibit 10.7 FIRST AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT THIS FIRST AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this ?Amendment?), by and between LifeStance Health, Inc., a Delaware corporation with its principal place of business in Bellevue, Washington (the ?Company?), and Michael K. Lester (the ?Executive?), is entered into effective as of June 1, 2020 (the ?Amendme |
|
| May 17, 2021 |
Exhibit 10.3 SECOND AMENDMENT TO CREDIT AGREEMENT This SECOND AMENDMENT TO CREDIT AGREEMENT (this ?Amendment?) dated as of February 1, 2021 by and among LifeStance Health Holdings, Inc., a Delaware corporation (the ?Borrower?), Lynnwood Intermediate Holdings, Inc. (?Holdings?), Capital One, National Association (?Capital One?), as administrative agent and as collateral agent (in each such capacity |
|
| May 13, 2021 |
LYNWOOD TOPCO, L.P. FORM OF CLASS B UNIT AWARD AGREEMENT EX-10.18 11 filename11.htm Exhibit 10.18 LYNWOOD TOPCO, L.P. FORM OF CLASS B UNIT AWARD AGREEMENT This Partnership Interest Award Agreement (this “Agreement”) is made effective as of [•] (the “Date of Grant”), by and between Lynwood TopCo, L.P., a Delaware limited partnership (the “Partnership”), and [•] (the “Participant”). Certain capitalized terms used in this Agreement are defined in Section 7 |
|
| May 13, 2021 |
FORM OF INDEMNIFICATION AGREEMENT EX-10.17 10 filename10.htm Exhibit 10.17 FORM OF INDEMNIFICATION AGREEMENT This Indemnification Agreement (this “Agreement”) is made and entered into as of [•], 2021, by and among LifeStance Health Group, Inc., a Delaware corporation (the “Company”), and [NAME OF DIRECTOR/OFFICER] (“Indemnitee”). WHEREAS, in light of the litigation costs and risks to directors and officers resulting from their ser |
|
| May 13, 2021 |
EX-10.1 2 filename2.htm Exhibit 10.1 Execution Version CREDIT AGREEMENT Dated as of May 14, 2020 among LYNNWOOD MERGERSUB, INC., as the Initial Borrower, which on the Closing Date shall be merged with and into, LIFESTANCE HEALTH HOLDINGS, INC., with LifeStance Health Holdings, Inc. surviving such merger as the Borrower, LYNNWOOD INTERMEDIATE HOLDINGS, INC., as Holdings, CAPITAL ONE, NATIONAL ASSOC |
|
| May 13, 2021 |
SECOND AMENDMENT TO CREDIT AGREEMENT Exhibit 10.3 SECOND AMENDMENT TO CREDIT AGREEMENT This SECOND AMENDMENT TO CREDIT AGREEMENT (this ?Amendment?) dated as of February 1, 2021 by and among LifeStance Health Holdings, Inc., a Delaware corporation (the ?Borrower?), Lynnwood Intermediate Holdings, Inc. (?Holdings?), Capital One, National Association (?Capital One?), as administrative agent and as collateral agent (in each such capacity |
|
| May 13, 2021 |
Exhibit 16.1 CliftonLarsonAllen LLP 10700 Northup Way Suite 200 Bellevue, WA 98004 425-250-6100 | Fax 425-250-6050 www.cliftonlarsonallen.com May 12, 2021 Securities and Exchange Commission Washington, D.C. 20549 We have read the statements that LifeStance Health Group, Inc. (?LifeStance?) made under ?Changes in Independent Registered Public Accounting Firm? of the Form S-1 that LifeStance filed o |
|
| May 13, 2021 |
AMENDED AND RESTATED EMPLOYMENT AGREEMENT EX-10.6 5 filename5.htm Exhibit 10.6 AMENDED AND RESTATED EMPLOYMENT AGREEMENT This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”), by and between LifeStance Health, Inc. (the “Company”), a Delaware corporation with its principal place of business in Bellevue, Washington, and Michael K. Lester (the “Executive”), is entered into as of May 14, 2020 (the “Effective Date”). W I T N E S S |
|
| May 13, 2021 |
AMENDED AND RESTATED EMPLOYMENT AGREEMENT EX-10.8 7 filename7.htm Exhibit 10.8 AMENDED AND RESTATED EMPLOYMENT AGREEMENT This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”), by and between LifeStance Health, Inc. (the “Company”), a Delaware corporation with its principal place of business in Bellevue, Washington, and Gwendolyn H. Booth (the “Executive”), is entered into as of May 14, 2020 (the “Effective Date”). W I T N E S |
|
| May 13, 2021 |
INDEPENDENT CONSULTING AGREEMENT Exhibit 10.10 INDEPENDENT CONSULTING AGREEMENT This INDEPENDENT CONSULTING AGREEMENT (this ?Agreement?) is made and entered into effective as of June 1, 2020 (the ?Effective Date?), by and among LifeStance Health, Inc. (?LifeStance?), a Delaware corporation, on the one hand, and Alert5 Consulting LLC (?Alert5?). a Washington limited liability company, and (with respect to Sections 2(a), 5 through |
|
| May 13, 2021 |
Table of Contents Confidential Draft Submission No. 3 As confidentially submitted to the Securities and Exchange Commission on May 12, 2021 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 LIFESTANCE HEALTH GROUP, INC. (Exact name of registrant as specified in its charter) Delaware 8000 86 |
|
| May 13, 2021 |
FIRST AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT EX-10.7 6 filename6.htm Exhibit 10.7 FIRST AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT THIS FIRST AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Amendment”), by and between LifeStance Health, Inc., a Delaware corporation with its principal place of business in Bellevue, Washington (the “Company”), and Michael K. Lester (the “Executive”), is entered into effective as of Ju |
|
| May 13, 2021 |
FIRST AMENDMENT TO CREDIT AGREEMENT Exhibit 10.2 Execution Version FIRST AMENDMENT TO CREDIT AGREEMENT This FIRST AMENDMENT TO CREDIT AGREEMENT (this ?Amendment?) dated as of November 4, 2020 by and among LifeStance Health Holdings, Inc., a Delaware corporation (the ?Borrower?), Lynnwood Intermediate Holdings, Inc. (?Holdings?), Capital One, National Association (?Capital One?), as administrative agent and as collateral agent (in ea |
|
| May 13, 2021 |
FORM OF MANAGEMENT SERVICES AGREEMENT Exhibit 10.19 FORM OF MANAGEMENT SERVICES AGREEMENT THIS MANAGEMENT SERVICES AGREEMENT (this ?Agreement?), effective as of [DATE], the (?Effective Date?), is entered into by and between Behavioral Health Practice Services, LLC (the ?Company?) and [ENTITY NAME], a [ENTITY TYPE] (the ?Practice?) (the Company and the Practice shall be collectively referred to as the ?Parties?). WHEREAS, the Practice |
|
| May 13, 2021 |
AMENDED AND RESTATED EMPLOYMENT AGREEMENT Exhibit 10.9 AMENDED AND RESTATED EMPLOYMENT AGREEMENT This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this ?Agreement?), by and between LifeStance Health, Inc. (the ?Company?), a Delaware corporation with its principal place of business in Bellevue, Washington, and Danish Qureshi (the ?Executive?), is entered into as of May 14, 2020 (the ?Effective Date?). W I T N E S S E T H WHEREAS, the Company |
|
| May 12, 2021 |
DRSLTR 1 filename1.htm ROPES & GRAY LLP PRUDENTIAL TOWER 800 BOYLSTON STREET BOSTON, MA 02199-3600 WWW.ROPESGRAY.COM May 12, 2021 BY EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Tracie Mariner; Brian Cascio Deanna Virginio; Jeffrey Gabor Re: LifeStance Health Group, Inc. Amendment No. 1 to Draft Registration Statement |
|
| April 12, 2021 |
Table of Contents Confidential Draft Submission No. 2 As confidentially submitted to the Securities and Exchange Commission on April 12, 2021 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 LIFESTANCE HEALTH GROUP, INC. (Exact name of registrant as specified in its charter) Delaware 8000 |
|
| April 12, 2021 |
ROPES & GRAY LLP PRUDENTIAL TOWER 800 BOYLSTON STREET BOSTON, MA 02199-3600 WWW.ROPESGRAY.COM April 12, 2021 BY EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Tracie Mariner; Brian Cascio Deanna Virginio; Jeffrey Gabor Re: LifeStance Health Group, Inc. Draft Registration Statement on Form S-1 Submitted February 16, 2021 |
|
| February 16, 2021 |
As confidentially submitted to the Securities and Exchange Commission on February 16, 2021 DRS 1 filename1.htm Table of Contents As confidentially submitted to the Securities and Exchange Commission on February 16, 2021 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 LIFESTANCE HEALTH GROUP, INC. (Exact name of registrant as specified in its charter) Delaware 8000 86-1832801 (S |
|
| February 16, 2021 |
Thomas Fraser T +1 617-951-7063 [email protected] February 16, 2021 CONFIDENTIAL SUBMISSION VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549 Re: LifeStance Health Group, Inc. Draft Registration Statement on Form S-1 Ladies and Gentlemen: On behalf of LifeStance Health Group, Inc. (the ?Company?), we are submittin |
